APRIL SKAGGS: Open Payments
NPI 1720727423 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$963 in 26 payments from 8 companies in 2025. Trend: 2023 $398 · 2024 $247 · 2025 $963
Food & beverage: $963
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $185 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $157 |
| Corium, LLC | 4 | $148 |
| Noven Therapeutics, LLC | 1 | $120 |
| Axsome Therapeutics, Inc. | 1 | $116 |
| Janssen Pharmaceuticals, Inc | 1 | $114 |
| Neurocrine BioSciences, Inc. | 1 | $105 |
| Alkermes, Inc. | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, Azstarys, Xelstrym, Auvelity, SPRAVATO, INGREZZA, VIVITROL.
Industry payments across KY — which companies pay providers there.
